Comparative evaluation of simvastatin gel in enhancing peri-implant osteoblastic activity during the Osseo integrative phase using Bone scintigraphy: A prospective case-control double blinded study

Simvastatin (SMV), a lipid lowering drug, can modulate the process of bone regeneration at the molecular and cellular levels. Its effect on the osseointegration of implants has been studied extensively on animals with assuring results with limited research on human subjects.